An Immune-Mediated Adverse Event Potentially Related to Rituximab
J Clin Rheumatol
.
2021 Dec 1;27(8S):S743-S744.
doi: 10.1097/RHU.0000000000001526.
Authors
Alojzija Hočevar
,
Armin Alibegović
1
,
Vesna Jurčić
2
,
Matija Tomšič
,
Žiga Rotar
3
Affiliations
1
Institute of Forensic Medicine, Faculty of Medicine.
2
Institute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
3
From the Department of Rheumatology, University Medical Centre Ljubljana.
PMID:
32833911
DOI:
10.1097/RHU.0000000000001526
No abstract available
MeSH terms
Humans
Rituximab* / adverse effects
Substances
Rituximab